Management of recurrent cervical cancer with peritoneal carcinomatosis with HIPEC
Cervical cancer is the fourth most common malignancy in women in the world; however, a substantial portion of these malignancies are declining with increasingly sophisticated screening. Unfortunately, recurrent cervical cancer has a dismal prognosis and its management continues to be a growing area...
Main Authors: | Taliya Lantsman, Marcos Lepe, Leslie Garrett, Martin Goodman, Meghan Shea |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-02-01
|
Series: | Gynecologic Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578921002137 |
Similar Items
-
Predictors of Recurrence of Peritoneal Carcinomatosis among Patients with Colorectal Cancer Following Cytoreductive Surgery alone versus Cytoreductive Surgery Plus HIPEC
by: Waheed Yousry Gareer, et al.
Published: (2022-06-01) -
Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study
by: Atuhani Burnett, et al.
Published: (2019-05-01) -
Anestesia en la Cirugía Citorreductora y la Quimioterapia hipertérmica intraperitoneal (HIPEC)
by: Carlos Mora Fernández, et al.
Published: (2014-06-01) -
THE ROLE OF HIPEC IN PERITONEAL CARCINOMATOSIS DUE TO COLORECTAL CANCER – PROCEDURE, COMPLICATIONS, AND LITERATURE EVIDENCE
by: Iulian Slavu, et al.
Published: (2020-12-01) -
Índice de carcinomatosis peritoneal y supervivencia global en pacientes llevados a cirugía citorreductora más quimioterapia intraperitoneal hipertérmica
by: Horacio N. López-Basave, et al.
Published: (2023-04-01)